Photodynamic therapy: A treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy [12]

British Journal of Ophthalmology

Volumn 87, Issue 7, 2003, Pages 925-927

  Chatterjee, S ^a   Gibson, Jonathan M ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE;

ADULT; CASE REPORT; CHOROID DISEASE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LABORATORY TEST; LETTER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PUNCTATE INNER CHOROIDOPATHY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; CHOROID DISEASES; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; PHOTOCHEMOTHERAPY;

EID: 0038798769     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.7.925     Document Type: Letter

References (15)

1. Brown J Jr, Folk JC, Reddy CV, et al. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 1996;103:1100-5.
2. Gass JDM. In: Stereoscopic atlas of macular disease diagnosis and treatment. Vol 2. St Louis: Mosby 1997:692-3.
3. Flaxel CJ, Owens SL, Mulholland B, et al. The use of corticosteroids for choroidal neovascularisation in young patients. Eye 1998; 12(Pt 2):266-72.
4. Olsen TW, Capone A Jr, Sternberg P Jr, et al. Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology 1996;103:2061-9.
5. Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol 2001;119:198-207.
6. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no 1. Ophthalmology 2001;108:841-52.
7. Anon. Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 2002;22:6-18.
8. Sickenberg M, Schmidt-Erfurth U, Miller JW, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000;118:327-36.
9. Karacorlu M, Karacorlu S, Ozdemir H, et al. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks(1). Am J Ophthalmol 2002;134:360.
10. Saperstein DA, Rosenfeld PJ, Bressler NM, et al, Verteporfin in Ocular Histoplasmosis (VOH) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Ophthalmology 2002;109:1499-505.
11. Spaide RF, Martin ML, Slakter J, et al. Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol 2002;134:62-8.
12. Dantas MA, Slakter JS, Negrao S, et al. Photodynamic therapy with verteporfin in mallatia leventinese. Ophthalmology. 2002;109:296-301.
13. Valmaggia C, Niederberger H, Helbig H. Photodynamic therapy for choroidal neovascularization in fundus flavimaculatus. Retina 2002;22:111-13.
14. Potter MJ, Szabo SM, Chan EY, et al. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol 2002;133:149-51
15. Battaglia Parodi M, Da Pozzo S, Toto L, et al. Photodynamic therapy for choroidal neovascularization associated with choroidal osteoma. Retina 2001;21:660-1.